Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 181 articles:
HTML format
Text format



Single Articles


    February 2018
  1. CHEN C, Soto-Gutierrez A, Baptista PM, Spee B, et al
    Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells.
    Gastroenterology. 2018 Feb 8. pii: S0016-5085(18)30166.
    PubMed     Text format     Abstract available


  2. TZARTZEVA K, Obi J, Rich NE, Parikh ND, et al
    Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30155.
    PubMed     Text format     Abstract available


    January 2018
  3. YOSHIKAWA T, Ohana M, Fukuda A
    High fever after radiofrequency ablation of hepatocellular carcinoma.
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30134.
    PubMed     Text format    


  4. SIMON-TALERO M, Roccarina D, Martinez J, Lampichler K, et al
    Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Gastroenterology. 2018 Jan 20. pii: S0016-5085(18)30069.
    PubMed     Text format     Abstract available


  5. MANCUSO A, Politi F, Maringhini A
    Portal Vein Thromboses in Cirrhosis: To Treat or Not to Treat?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36673.
    PubMed     Text format    


  6. WOOD CP, Rowe IA
    What Are the Benefits of Anticoagulation for Portal Vein Thrombosis in Individuals With Cirrhosis?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36671.
    PubMed     Text format    


  7. CHEN H, Lv Y, Han G
    Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: Not Only Recanalize the Portal Vein.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36672.
    PubMed     Text format    


  8. HORVAT N, Ragucci M, Mannelli L
    Hepatic Mass in a Patient With Bladder Cancer History.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)35643.
    PubMed     Text format    


  9. QI X, Valla DC, Guo X
    Anticoagulation for Portal Vein Thrombosis in Cirrhosis: Selection of Appropriate Patients.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36669.
    PubMed     Text format    


  10. DU K, Hyun J, Premont RT, Choi SS, et al
    Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Hepatic Stellate Cell Activation.
    Gastroenterology. 2018 Jan 3. pii: S0016-5085(18)30002.
    PubMed     Text format     Abstract available


    December 2017
  11. WU X, Dao Thi VL, Liu P, Takacs CN, et al
    Pan-Genotype Hepatitis E Virus Replication in Stem Cell-derived Hepatocellular Systems.
    Gastroenterology. 2017 Dec 22. pii: S0016-5085(17)36303.
    PubMed     Text format     Abstract available


  12. ZHANG S, Nguyen LH, Zhou K, Tu HC, et al
    Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice without Affecting Regeneration.
    Gastroenterology. 2017 Dec 20. pii: S0016-5085(17)36717.
    PubMed     Text format     Abstract available


    November 2017
  13. MARQUARDT JU
    The Role of Transforming Growth Factor-beta in Human Hepatocarcinogenesis: Mechanistic and Therapeutic Implications from an Integrative Multiomics Approach.
    Gastroenterology. 2017 Nov 21. pii: S0016-5085(17)36373.
    PubMed     Text format    


  14. BI D, Malikowski TM, Sweetser S
    Portal Hypertension and Unexplained Diarrhea in an 80-year-old man.
    Gastroenterology. 2017 Nov 6. pii: S0016-5085(17)36339.
    PubMed     Text format    


  15. KAKAR S, Borhani AA, Malik SM
    A Liver Full of Stars: Hepatostellular!
    Gastroenterology. 2017 Nov 4. pii: S0016-5085(17)35453.
    PubMed     Text format    


  16. DEBES JD, van Tilborg M, Groothuismink ZMA, Hansen BE, et al
    Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-acting Antivirals.
    Gastroenterology. 2017 Nov 1. pii: S0016-5085(17)36295.
    PubMed     Text format     Abstract available


  17. VANWAGNER LB, Ning H, Allen NB, Ajmera V, et al
    Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2017;153:1260-1272.
    PubMed     Text format     Abstract available


  18. D'MELLO C, Almishri W, Liu H, Swain MG, et al
    Interactions Between Platelets and Inflammatory Monocytes Affect Sickness Behavior in Mice With Liver Inflammation.
    Gastroenterology. 2017;153:1416-1428.
    PubMed     Text format     Abstract available


  19. MOON H, Ju HL, Chung SI, Cho KJ, et al
    Transforming Growth Factor-beta Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Gastroenterology. 2017;153:1378-1391.
    PubMed     Text format     Abstract available


    October 2017
  20. MAZZAFERRO V, Sposito C, Zhou J, Pinna AD, et al
    Metroticket 2.0 Model for Analysis of Competing Risks of Death Following Liver Transplantation for Hepatocellular Carcinoma.
    Gastroenterology. 2017 Oct 5. pii: S0016-5085(17)36184.
    PubMed     Text format     Abstract available


  21. CAO W, Chen K, Bolkestein M, Yin Y, et al
    Dynamics of Proliferative and Quiescent Stem Cells in Liver Homeostasis and Injury.
    Gastroenterology. 2017;153:1133-1147.
    PubMed     Text format     Abstract available


  22. HSU EK, Shaffer ML, Gao L, Sonnenday C, et al
    Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
    Gastroenterology. 2017;153:988-995.
    PubMed     Text format     Abstract available


  23. CHEN ZH, Yu YP, Tao J, Liu S, et al
    MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.
    Gastroenterology. 2017;153:1120-1132.
    PubMed     Text format     Abstract available


    September 2017
  24. ZHANG K, Kim H, Fu Z, Qiu Y, et al
    Deficiency of the Mitochondrial NAD Kinase Causes Stress-induced hepatic steatosis in mice.
    Gastroenterology. 2017 Sep 15. pii: S0016-5085(17)36150.
    PubMed     Text format     Abstract available


  25. ENGELHOLM LH, Riaz A, Serra D, Dagnaes-Hansen F, et al
    CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
    Gastroenterology. 2017 Sep 15. pii: S0016-5085(17)36148.
    PubMed     Text format     Abstract available


  26. CHEN J, Zaidi S, Rao S, Chen JS, et al
    Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor beta Pathway Short title: Prognostic significance of TGF-beta signature in liver cancer.
    Gastroenterology. 2017 Sep 14. pii: S0016-5085(17)36144.
    PubMed     Text format     Abstract available


  27. KESAR V, Swaminath A
    Hepatic masses in a patient in Inflammatory bowel disease.
    Gastroenterology. 2017 Sep 9. pii: S0016-5085(17)36140.
    PubMed     Text format    


  28. ESO Y, Mishima M, Fukuda A
    An Unusual Cause of Hepatic Dysfunction.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)35460.
    PubMed     Text format    


    August 2017
  29. MAAN R, Feld JJ
    Risk for hepatocellular carcinoma after HCV antiviral therapy with direct-acting antivirals: case closed?
    Gastroenterology. 2017 Aug 31. pii: S0016-5085(17)36085.
    PubMed     Text format    


  30. CRISMALE JF, Ward SC, Ahmad J
    An Unusual Cause of Abdominal Pain and Biliary Obstruction in a Patient with Hepatocellular Carcinoma.
    Gastroenterology. 2017 Aug 30. pii: S0016-5085(17)36074.
    PubMed     Text format    


  31. KIM K, Ryu D, Dongiovanni P, Ozcan L, et al
    Degradation of PHLPP2 by KCTD17, via a Glucagon-dependent Pathway, Promotes Hepatic Steatosis.
    Gastroenterology. 2017 Aug 28. pii: S0016-5085(17)36072.
    PubMed     Text format     Abstract available


  32. SCHMIDT-MARTIN D, Armstrong MJ, Rowe IA
    Transplant-Free Survival Rates After Covered Transjugular Intrahepatic Portosystemic Shunt.
    Gastroenterology. 2017 Aug 3. pii: S0016-5085(17)35885.
    PubMed     Text format    


  33. BOLTE FJ, O'Keefe AC, Webb LM, Serti E, et al
    Intra-hepatic Depletion of Mucosal Associated Invariant T cells in Hepatitis C Virus-induced Liver Inflammation.
    Gastroenterology. 2017 Aug 2. pii: S0016-5085(17)35975.
    PubMed     Text format     Abstract available


    July 2017
  34. PATEL YA, Imperial J, Muir AJ, Anstee QM, et al
    Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations from the Liver Forum.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35955.
    PubMed     Text format     Abstract available


  35. LENS S, Alvarado E, Marino Z, Londono MC, et al
    Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.
    Gastroenterology. 2017 Jul 19. pii: S0016-5085(17)35922.
    PubMed     Text format     Abstract available


  36. YU MW, Lin CL, Liu CJ, Yang SH, et al
    Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.
    Gastroenterology. 2017 Jul 12. pii: S0016-5085(17)35866.
    PubMed     Text format     Abstract available


  37. KING A, Houlihan DD, Kavanagh D, Haldar D, et al
    Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.
    Gastroenterology. 2017;153:233-248.
    PubMed     Text format     Abstract available


  38. KHAMRI W, Abeles RD, Hou TZ, Anderson AE, et al
    Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.
    Gastroenterology. 2017;153:263-276.
    PubMed     Text format     Abstract available


    June 2017
  39. ZHOU G, Sprengers D, Boor PPC, Doukas M, et al
    Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-infiltrating T cells in Hepatocellular Carcinomas.
    Gastroenterology. 2017 Jun 22. pii: S0016-5085(17)35802.
    PubMed     Text format     Abstract available


  40. KANWAL F, Kramer J, Asch SM, Chayanupatkul M, et al
    Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35797.
    PubMed     Text format     Abstract available


  41. VANCLOOSTER A, van Deursen C, Jaspers R, Cassiman D, et al
    Proton pump inhibitors decrease phlebotomy need in HFE hemochromatosis: double-blind randomized placebo-controlled trial.
    Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35740.
    PubMed     Text format    


  42. NANO J, Ghanbari M, Wang W, de Vries PS, et al
    Epigenome-wide Association Study Identifies Methylation Sites Associated With Liver Enzymes and Hepatic Steatosis.
    Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35737.
    PubMed     Text format     Abstract available


  43. SIA D, Jiao Y, Martinez-Quetglas I, Kuchuk O, et al
    Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
    Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35741.
    PubMed     Text format     Abstract available


  44. MIDDLETON MS, Heba ER, Hooker CA, Bashir MR, et al
    Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-assigned Steatosis Grades of Liver Biopsies from Adults with Nonalcoholic Steatohepatitis.
    Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35739.
    PubMed     Text format     Abstract available


  45. JIN B, Du G, Li T
    Right Upper Abdominal Distension and Discomfort Caused by a Massive Hepatic Tumor.
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(16)35356.
    PubMed     Text format    


  46. JIN H, Wang C, Jin G, Ruan H, et al
    Regulator of Calcineurin 1 Gene Isoform 4, Downregulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Growth of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35687.
    PubMed     Text format     Abstract available


  47. CANNON MD, Heneghan MA
    Endoscopy in Pregnant Women with Liver Cirrhosis.
    Gastroenterology. 2017 Jun 1. pii: S0016-5085(17)35602.
    PubMed     Text format    


  48. WEILER SME, Pinna F, Wolf T, Lutz T, et al
    Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Gastroenterology. 2017;152:2037-2051.
    PubMed     Text format     Abstract available


    May 2017
  49. LOFFREDO L, Pastori D, Farcomeni A, Violi F, et al
    Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: a Systematic Review and Meta-Analysis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35552.
    PubMed     Text format     Abstract available


  50. KHAN MA, Cholankeril G, Howden CW
    Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding?
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35404.
    PubMed     Text format    


  51. TAN HK, Leow WQ, Chang PE
    Ruxolitinib for the Treatment of Portal Hypertension in a Patient With Primary Myelofibrosis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(16)35073.
    PubMed     Text format    


  52. ASSARAF J, Weiss N, Thabut D
    Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood-Brain Barrier Drug Transport.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35403.
    PubMed     Text format    


  53. ROCCARO GA, Goldberg DS
    Early Detection of Hepatocellular Carcinoma after Treatment With Direct-Acting Antivirals: Selection Bias or Biologically Plausible?
    Gastroenterology. 2017 May 3. pii: S0016-5085(17)35551.
    PubMed     Text format    


  54. ABATE N, Chandalia M
    Risk of Obesity-Related Cardiometabolic Complications in Special Populations: A Crisis in Asians.
    Gastroenterology. 2017;152:1647-1655.
    PubMed     Text format     Abstract available


  55. CAMILLERI M, Malhi H, Acosta A
    Gastrointestinal Complications of Obesity.
    Gastroenterology. 2017;152:1656-1670.
    PubMed     Text format     Abstract available


  56. LAI KKY, Kweon SM, Chi F, Hwang E, et al
    Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
    Gastroenterology. 2017;152:1477-1491.
    PubMed     Text format     Abstract available


    April 2017
  57. KALYAN A, Kulik L
    Multi-disciplinary Care in Hepatocellular Carcinoma: Where Do We Go from Here?
    Gastroenterology. 2017 Apr 28. pii: S0016-5085(17)35538.
    PubMed     Text format    


  58. CUI L, Nakano K, Obchoei S, Setoguchi K, et al
    Small Nucleolar Noncoding RNA SNORA23, Upregulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of SYNE2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Gastroenterology. 2017 Apr 5. pii: S0016-5085(17)35402.
    PubMed     Text format     Abstract available


  59. PAN LH, Zhao C, Ma YL
    Is Y90 Radioembolization Superior or Comparable to Transarterial Chemoembolization for Treating Hepatocellular Carcinoma?
    Gastroenterology. 2017 Apr 3. pii: S0016-5085(17)30221.
    PubMed     Text format    


  60. DURAN R, Deltenre P, Denys A
    RE: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2017 Apr 1. pii: S0016-5085(17)30224.
    PubMed     Text format    


  61. NICOLETTI P, Aithal GP, Bjornsson ES, Andrade RJ, et al
    Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
    Gastroenterology. 2017;152:1078-1089.
    PubMed     Text format     Abstract available


  62. AN SY, Jang YJ, Lim HJ, Han J, et al
    Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.
    Gastroenterology. 2017;152:1174-1186.
    PubMed     Text format     Abstract available


  63. SONG CQ, Li Y, Mou H, Moore J, et al
    Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.
    Gastroenterology. 2017;152:1161-1173.
    PubMed     Text format     Abstract available


    March 2017
  64. YOUNG S, Golzarian J
    Regarding: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2017 Mar 31. pii: S0016-5085(17)30225.
    PubMed     Text format    


  65. GARIN E, Pallard X, Edeline J
    Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?
    Gastroenterology. 2017 Mar 31. pii: S0016-5085(17)30222.
    PubMed     Text format    


  66. ZHANG W, He H, Zang M, Wu Q, et al
    Genetic Features of Aflatoxin-associated Hepatocellular Carcinomas.
    Gastroenterology. 2017 Mar 28. pii: S0016-5085(17)30333.
    PubMed     Text format     Abstract available


  67. HOWELL J, Thompson AJ
    Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One Behind.
    Gastroenterology. 2017 Mar 28. pii: S0016-5085(17)30334.
    PubMed     Text format    


  68. DURNO C, Boland CR, Cohen S, Dominitz JA, et al
    Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Gastroenterology. 2017 Mar 22. pii: S0016-5085(17)30175.
    PubMed     Text format     Abstract available


  69. NASR P, Forsgren MF, Ignatova S, Dahlstrom N, et al
    Using a 3% Proton Density Fat Fraction as a Cut-off Value Increases Sensitivity of Detection of Hepatic Steatosis, Based on Results from Histopathology Analysis.
    Gastroenterology. 2017 Mar 9. pii: S0016-5085(17)30267.
    PubMed     Text format     Abstract available


  70. CHEN B, Wei W, Ma L, Yang B, et al
    Computational Discovery of Niclosamide Ethanolamine, A Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells in Vitro and in Mice by Inhibiting CDC37 Signaling.
    Gastroenterology. 2017 Mar 8. pii: S0016-5085(17)30264.
    PubMed     Text format     Abstract available


  71. SERPER M, Taddei TH, Mehta R, D'Addeo K, et al
    Association of Provider Specialty and Multi-disciplinary Care with Hepatocellular Carcinoma Treatment and Mortality.
    Gastroenterology. 2017 Mar 7. pii: S0016-5085(17)30265.
    PubMed     Text format     Abstract available


  72. MANCUSO A
    Classification of Portal Vein Thrombosis in Cirrhosis.
    Gastroenterology. 2017 Mar 3. pii: S0016-5085(17)30135.
    PubMed     Text format    


  73. NAULT JC
    Cancer Gene Discovery in Hepatocellular Carcinoma: The CRISPR/CAS9 Accelerator.
    Gastroenterology. 2017 Mar 1. pii: S0016-5085(17)30218.
    PubMed     Text format    


  74. SIA D, Villanueva A, Friedman SL, Llovet JM, et al
    Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
    Gastroenterology. 2017;152:745-761.
    PubMed     Text format     Abstract available


    February 2017
  75. CHAVEZ-TALAVERA O, Tailleux A, Lefebvre P, Staels B, et al
    Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD.
    Gastroenterology. 2017 Feb 15. pii: S0016-5085(17)30157.
    PubMed     Text format     Abstract available


  76. JACOBSON IM, Lawitz E, Kwo PY, Hezode C, et al
    Safety and Efficacy of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Infection and Compensated Cirrhosis: an Integrated Analysis.
    Gastroenterology. 2017 Feb 10. pii: S0016-5085(17)30150.
    PubMed     Text format     Abstract available


  77. NAKAGAWA H, Mizukoshi E, Kobayashi E, Tamai T, et al
    Association Between High-avidity T-cell Receptors, Induced by Alpha Fetoprotein-derived Peptides, and Anti-tumor Effects in Patients with Hepatocellular Carcinoma.
    Gastroenterology. 2017 Feb 7. pii: S0016-5085(17)30132.
    PubMed     Text format     Abstract available


  78. MATSUURA K, Sawai H, Ikeo K, Ogawa S, et al
    Genome-wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Gastroenterology. 2017 Feb 2. pii: S0016-5085(17)30130.
    PubMed     Text format     Abstract available


  79. RAVI S, Axley P, Jones D, Kodali S, et al
    Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Gastroenterology. 2017 Feb 1. pii: S0016-5085(16)35535.
    PubMed     Text format    


  80. PATEL SH, Camargo FD, Yimlamai D
    Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.
    Gastroenterology. 2017;152:533-545.
    PubMed     Text format     Abstract available


  81. PARK CC, Nguyen P, Hernandez C, Bettencourt R, et al
    Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2017;152:598-607.
    PubMed     Text format     Abstract available


  82. MARKOVA M, Pivovarova O, Hornemann S, Sucher S, et al
    Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Gastroenterology. 2017;152:571-585.
    PubMed     Text format     Abstract available


    January 2017
  83. HUANG Z, Zhang F, Luo Z
    Intrahepatic Biliary Duct Dilatation With an Unusual Choledochoscope Image.
    Gastroenterology. 2017 Jan 31. pii: S0016-5085(16)35177.
    PubMed     Text format    


  84. ALONSO C, Fernandez-Ramos D, Varela-Rey M, Martinez-Arranz I, et al
    Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.
    Gastroenterology. 2017 Jan 26. pii: S0016-5085(17)30072.
    PubMed     Text format     Abstract available


  85. MASSAFRA V, Milona A, Vos HR, Ramos RJ, et al
    Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.
    Gastroenterology. 2017 Jan 24. pii: S0016-5085(17)30054.
    PubMed     Text format     Abstract available


  86. SILVA-JUNIOR G, Turon F, Baiges A, Cerda E, et al
    Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Porto-systemic Shunts in Patients With Portal Hypertension.
    Gastroenterology. 2017 Jan 24. pii: S0016-5085(17)30051.
    PubMed     Text format     Abstract available


  87. GOLDBERG D, Ditah IC, Saeian K, Lalehzari M, et al
    Changes in the Prevalence of Hepatitis C Virus Infection, Non-alcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients with Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Gastroenterology. 2017 Jan 11. pii: S0016-5085(17)30014.
    PubMed     Text format     Abstract available


  88. ASAI Y, Yamada T, Tsukita S, Takahashi K, et al
    Activation of the Hypoxia Inducible Factor 1 Alpha Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
    Gastroenterology. 2017 Jan 11. pii: S0016-5085(17)30012.
    PubMed     Text format     Abstract available


  89. LIN XM, Hu L, Gu J, Wang RY, et al
    Choline Kinase Alpha Mediates Interactions Between the Epidermal Growth Factor Receptor and mTORC2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
    Gastroenterology. 2017 Jan 5. pii: S0016-5085(17)30001.
    PubMed     Text format     Abstract available


  90. WOODEN B, Goossens N, Hoshida Y, Friedman SL, et al
    Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.
    Gastroenterology. 2017;152:53-67.
    PubMed     Text format     Abstract available


    December 2016
  91. NAULT JC, Couchy G, Balabaud C, Morcrette G, et al
    Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Gastroenterology. 2016 Dec 7. pii: S0016-5085(16)35440.
    PubMed     Text format     Abstract available


  92. RICH N, Singal AG
    Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Potential New Challenge for Hepatocellular Carcinoma Surveillance.
    Gastroenterology. 2016;151:1246-1248.
    PubMed     Text format    


    November 2016
  93. WHITE DL, Thrift AP, Kanwal F, Davila J, et al
    Incidence of Hepatocellular Carcinoma in all 50 United States, From 2000 Through 2012.
    Gastroenterology. 2016 Nov 23. pii: S0016-5085(16)35389.
    PubMed     Text format     Abstract available


  94. SINGAL AG, Tiro JA, Marrero JA, McCallister K, et al
    Mailed Outreach Program Increases Ultrasound Screening of Patients with Cirrhosis for Hepatocellular Carcinoma.
    Gastroenterology. 2016 Nov 5. pii: S0016-5085(16)35321.
    PubMed     Text format     Abstract available


    October 2016
  95. SOYSA DR, Crispe IN
    Sub-capsular Hepatic Dendritic Cells: Hiding in Plain Sight.
    Gastroenterology. 2016 Oct 27. pii: S0016-5085(16)35277.
    PubMed     Text format    


  96. MEHTA N, Yao FY
    Trans-arterial radioembolization for hepatocellular carcinoma: who, when... and Y(90)?
    Gastroenterology. 2016 Oct 27. pii: S0016-5085(16)35278.
    PubMed     Text format    


  97. PARK HM, Russo KA, Karateev G, Park M, et al
    A System for In Vivo Imaging of Hepatic Free Fatty Acid Uptake.
    Gastroenterology. 2016 Oct 11. pii: S0016-5085(16)35185.
    PubMed     Text format     Abstract available


  98. WEERSINK RA, Drenth JP, Borgsteede SD
    Altered Pharmacokinetics of Statins Explain Increased Risk of Rhabdomyolysis in Advanced Cirrhosis.
    Gastroenterology. 2016 Oct 3. pii: S0016-5085(16)35074.
    PubMed     Text format    


  99. LO GH
    Did Statins Really Improve Survival in Cirrhotic Patients With a History of Variceal Bleeding?
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35075.
    PubMed     Text format    


  100. SOOKOIAN S, Pirola CJ
    The Exact Mechanism by Which Hepatic Transmembrane 6 Superfamily Member 2 Modulates Triglyceride Metabolism Is Still Uncertain.
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35129.
    PubMed     Text format    


    September 2016
  101. ZHANG F, Sodroski C, Cha H, Li Q, et al
    Infection of Hepatocytes with HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Upregulating SMAD6 and SMAD7.
    Gastroenterology. 2016 Sep 29. pii: S0016-5085(16)35128.
    PubMed     Text format     Abstract available


  102. PIKARSKY E, Heikenwalder M
    Focal and Local: About Ectopic Lymphoid Structures, Intrahepatic Myeloid Aggregates for T-Cell Expansion, and Other Immune Cell Aggregates in the Liver.
    Gastroenterology. 2016 Sep 28. pii: S0016-5085(16)35124.
    PubMed     Text format    


  103. BUREAU C, Thabut D, Oberti F, Dharancy S, et al
    Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Gastroenterology. 2016 Sep 20. pii: S0016-5085(16)35110.
    PubMed     Text format     Abstract available


  104. NAHON P, Bourcier V, Layese R, Audureau E, et al
    Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
    Gastroenterology. 2016 Sep 15. pii: S0016-5085(16)35070.
    PubMed     Text format     Abstract available


  105. TSAI CF, Chen MH, Wang YP, Chu CJ, et al
    Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in Population Study.
    Gastroenterology. 2016 Sep 14. pii: S0016-5085(16)35032.
    PubMed     Text format     Abstract available


  106. GAO Q, Wang ZC, Duan M, Lin YH, et al
    Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gastroenterology. 2016 Sep 14. pii: S0016-5085(16)35033.
    PubMed     Text format     Abstract available


  107. MARTINEZ-QUETGLAS I, Pinyol R, Dauch D, Torrecilla S, et al
    IGF2 is Upregulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and is an Actionable Oncogene Product in Experimental Models.
    Gastroenterology. 2016 Sep 7. pii: S0016-5085(16)35026.
    PubMed     Text format     Abstract available


  108. GUO S, Xu Y, Zhang Z
    Repeated Hepatolithiasis and Unknown Mass in Cholangiography.
    Gastroenterology. 2016 Sep 1. pii: S0016-5085(16)34656.
    PubMed     Text format    


    August 2016
  109. KALMAN RS, Goldberg DS
    Obeticholic Acid Reduces Bacterial Translocation and Inhibits Intestinal Inflammation in Cirrhotic Rats.
    Gastroenterology. 2016 Aug 28. pii: S0016-5085(16)34977.
    PubMed     Text format    


  110. SARIN SK, Philips CA, Kamath PS, Choudhary A, et al
    Towards a Comprehensive New Classification of Portal Vein Thrombosis in Patients with Cirrhosis: A Commentary.
    Gastroenterology. 2016 Aug 26. pii: S0016-5085(16)34975.
    PubMed     Text format    


  111. SALEM R, Gordon AC, Mouli S, Hickey R, et al
    Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2016 Aug 26. pii: S0016-5085(16)34971.
    PubMed     Text format     Abstract available


  112. GRUNWALD B, Harant V, Schaten S, Fruhschutz M, et al
    Pancreatic Pre-malignant Lesions Secrete TIMP1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Pre-Metastatic Niche in the Liver.
    Gastroenterology. 2016 Aug 6. pii: S0016-5085(16)34890.
    PubMed     Text format     Abstract available


    July 2016
  113. SHERMAN M
    Hepatitis B vaccination: Putting hepatologists out of business?
    Gastroenterology. 2016 Jul 22. pii: S0016-5085(16)34819.
    PubMed     Text format    


  114. GANE E, Poordad F, Wang S, Asatryan A, et al
    High Efficacy of ABT-493 and ABT-530 in Patients with HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.
    Gastroenterology. 2016 Jul 22. pii: S0016-5085(16)34816.
    PubMed     Text format     Abstract available


  115. MASON WS, Gill US, Litwin S, Zhou Y, et al
    HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.
    Gastroenterology. 2016 Jul 21. pii: S0016-5085(16)34808.
    PubMed     Text format     Abstract available


  116. CABILLIC F, Corlu A
    Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular Carcinoma.
    Gastroenterology. 2016 Jul 18. pii: S0016-5085(16)34788.
    PubMed     Text format     Abstract available


  117. SHIN JY, Azoulay L, Filion KB
    Statin Use in Patients With Hepatitis C-related Cirrhosis: True Benefit or Immortal Time Bias?
    Gastroenterology. 2016 Jul 1. pii: S0016-5085(16)34434.
    PubMed     Text format    


    June 2016
  118. JAESCHKE H
    Mechanisms of Acetaminophen Hepatotoxicity: Do We Need JNK for Cell Death?
    Gastroenterology. 2016 Jun 30. pii: S0016-5085(16)34616.
    PubMed     Text format    


  119. TEUFEL A, Dufour JF
    Two-Step Forward Genetic Screen in Mice Identifies the Ral Pathway as a Central Drug Target in Hepatocellular Carcinoma.
    Gastroenterology. 2016 Jun 29. pii: S0016-5085(16)34706.
    PubMed     Text format    


  120. RAHMAN K, Desai C, Iyer SS, Thorn NE, et al
    Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.
    Gastroenterology. 2016 Jun 21. pii: S0016-5085(16)34679.
    PubMed     Text format     Abstract available


    May 2016
  121. KLINGE MJ, Borhani AA, Malik SM
    Hepatitis C and Numerous Disappearing Hepatic Nodules: No-dule C It, No-dule Don't.
    Gastroenterology. 2016 May 27. pii: S0016-5085(16)30099.
    PubMed     Text format    


  122. KODAMA T, Bard-Chapeau EA, Newberg JY, Kodama M, et al
    Two-step Forward Genetic Screen in Mice Identifies Ral GTPase-activating Proteins as Suppressors of Hepatocellular Carcinoma.
    Gastroenterology. 2016 May 10. pii: S0016-5085(16)34392.
    PubMed     Text format     Abstract available


  123. MANCINA RM, Dongiovanni P, Petta S, Pingitore P, et al
    The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
    Gastroenterology. 2016;150:1219-1230.
    PubMed     Text format     Abstract available


  124. NEWSOME PN
    Entering the GOLDEN Age for Therapies in NASH.
    Gastroenterology. 2016;150:1073-6.
    PubMed     Text format    


    April 2016
  125. PALMER RH
    Biliary Cirrhosis Treated With Ursodeoxycholic Acid.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00363.
    PubMed     Text format    


  126. SUGA T, Arai H, Takayama H
    A Rare Cause of Esophageal Varices.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00212.
    PubMed     Text format    


  127. GINES P
    Management of Hepatorenal Syndrome in the Era of Acute-on-Chronic Liver Failure: Telipressin and Beyond.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)34324.
    PubMed     Text format    


  128. SOREIDE K, Watson MM, Hagland HR
    Deciphering the Molecular Code to Colorectal Liver Metastasis Biology Through Microsatellite Alterations and Allelic Loss: The Good, the Bad, and the Ugly.
    Gastroenterology. 2016;150:811-4.
    PubMed     Text format    


  129. BIRKBAK NJ, Andersen JB
    Heterogeneity Among Liver Cancer--A Hurdle to Optimizing Therapy.
    Gastroenterology. 2016;150:818-21.
    PubMed     Text format    


  130. CALDERONE V, Gallego J, Fernandez-Miranda G, Garcia-Pras E, et al
    Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.
    Gastroenterology. 2016;150:982-97.
    PubMed     Text format     Abstract available


    March 2016
  131. DI MARCO V, Calvaruso V, Ferraro D, Bavetta MG, et al
    Effects of Viral Eradication in Patients with HCV and Cirrhosis Differ With Stage of Portal Hypertension.
    Gastroenterology. 2016 Mar 31. pii: S0016-5085(16)30049.
    PubMed     Text format     Abstract available


  132. CHIN JL, Chan G, Ryan JD
    Noninvasive Assessment of Liver Fibrosis and Cirrhosis With Ultrasound-based Elastography in Alcohol-related Liver Disease.
    Gastroenterology. 2016 Mar 25. pii: S0016-5085(16)00301.
    PubMed     Text format    


  133. NEPHEW LD, Goldberg DS
    Impact of Anticoagulation on Upper Gastrointestinal Bleeding in Cirrhosis.
    Gastroenterology. 2016 Mar 24. pii: S0016-5085(16)00377.
    PubMed     Text format    


  134. ROCKEY DC
    A new treatment for portal hypertension?
    Gastroenterology. 2016 Mar 23. pii: S0016-5085(16)00368.
    PubMed     Text format    


  135. LASSAILLY G, Caiazzo R, Pattou F, Mathurin P, et al
    Perspectives on Treatment for Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Mar 10. pii: S0016-5085(16)00323.
    PubMed     Text format     Abstract available


  136. FERNANDES D, Vilaca S, Rolanda C
    Epigastric Pain in a Patient With Nodular Regenerative Hyperplasia.
    Gastroenterology. 2016;150:572-3.
    PubMed     Text format    


  137. TAOULI B, Serfaty L
    Magnetic Resonance Imaging/Elastography Is Superior to Transient Elastography for Detection of Liver Fibrosis and Fat in Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2016;150:553-6.
    PubMed     Text format    


  138. IMAJO K, Kessoku T, Honda Y, Tomeno W, et al
    Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Gastroenterology. 2016;150:626-637.
    PubMed     Text format     Abstract available


  139. REINKE H, Asher G
    Circadian Clock Control of Liver Metabolic Functions.
    Gastroenterology. 2016;150:574-80.
    PubMed     Text format     Abstract available


  140. UTHAYA KUMAR DB, Chen CL, Liu JC, Feldman DE, et al
    TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.
    Gastroenterology. 2016;150:707-19.
    PubMed     Text format     Abstract available


    February 2016
  141. SCHATTENBERG JM, Lee MS
    Extracellular Vesicles as Messengers between Hepatocytes and Macrophages in Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Feb 27. pii: S0016-5085(16)00255.
    PubMed     Text format    


  142. DAS S, Mahakkanukrauh P, Ho CC
    The Burden of Gastrointestinal, Liver, and Pancreatic Diseases: The Global Scenario.
    Gastroenterology. 2016 Feb 27. pii: S0016-5085(16)00136.
    PubMed     Text format    


  143. MACHADO MV, Diehl AM
    Pathogenesis of Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Feb 26. pii: S0016-5085(16)00257.
    PubMed     Text format     Abstract available


  144. YOUNOSSI Z, Park H, Henry L, Adeyemi A, et al
    Extra-Hepatic Manifestations of Hepatitis C-a Meta-Analysis of Prevalence, Quality of Life, and Economic Burden.
    Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00230.
    PubMed     Text format     Abstract available


  145. SANYAL AJ, Miller V
    Regulatory Science and Drug Approval for Alcoholic and Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00235.
    PubMed     Text format    


  146. ZHOU SL, Zhou ZJ, Hu ZQ, Huang XW, et al
    Tumor-Associated Neutrophils Recruit Macrophages and T-regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00231.
    PubMed     Text format     Abstract available


  147. GLASS L, Sharma P
    Evidence-Based Therapeutic Options for Hepatorenal Syndrome.
    Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00241.
    PubMed     Text format    


  148. MATSUSHITA H, Yang YM, Pandol SJ, Seki E, et al
    Exosomal MIF: A Potential New Biomarker and Therapeutic Target for Pancreatic Cancer.
    Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00242.
    PubMed     Text format    


  149. BOYER TD, Sanyal AJ, Wong F, Frederick RT, et al
    Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1.
    Gastroenterology. 2016 Feb 16. pii: S0016-5085(16)00217.
    PubMed     Text format     Abstract available


  150. RATZIU V, Harrison S, Francque S, Bedossa P, et al
    Elafibranor, an Agonist of the Peroxisome Proliferator-activated Receptor-alpha and -delta, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
    Gastroenterology. 2016 Feb 10. pii: S0016-5085(16)00140.
    PubMed     Text format     Abstract available


  151. WANG L, Yin J, Wang X, Shao M, et al
    C-type Lectin-like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of PI3K Subunits.
    Gastroenterology. 2016 Feb 5. pii: S0016-5085(16)00133.
    PubMed     Text format     Abstract available


  152. BERRY K, Ioannou GN
    Reply.
    Gastroenterology. 2016;150:535-7.
    PubMed     Text format    


  153. VITALE A, Volk ML, Senzolo M, Frigo AC, et al
    Estimation of Liver Transplant Related Survival Benefit: the Devil Is in The Details.
    Gastroenterology. 2016;150:534-5.
    PubMed     Text format    


  154. GOLDBERG DS, Charlton M
    Usefulness of Liver Transplantation in the Elderly: The Converging Impact of Risk and Benefit.
    Gastroenterology. 2016;150:306-9.
    PubMed     Text format    


  155. SU F, Yu L, Berry K, Liou IW, et al
    Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit.
    Gastroenterology. 2016;150:441-53.
    PubMed     Text format     Abstract available


    January 2016
  156. KRISS M, Wachs M, Attwell A
    An Unusual Cause of Right Upper Quadrant Pain in a Patient With Prior Liver Transplantation for Primary Sclerosing Cholangitis.
    Gastroenterology. 2016 Jan 28. pii: S0016-5085(15)01070.
    PubMed     Text format    


  157. GOOSSENS N, Hoshida Y
    Is hepatocellular cancer the same disease in alcoholic and non-alcoholic fatty liver diseases?
    Gastroenterology. 2016 Jan 16. pii: S0016-5085(16)00045.
    PubMed     Text format    


  158. ABRALDES JG, Villanueva C, Aracil C, Turnes J, et al
    Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.
    Gastroenterology. 2016 Jan 13. pii: S0016-5085(16)00043.
    PubMed     Text format     Abstract available


  159. FAN Y, Lu H, Guo Y, Zhu T, et al
    Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice.
    Gastroenterology. 2016 Jan 13. pii: S0016-5085(16)00044.
    PubMed     Text format     Abstract available


  160. BRUIX J, Reig M, Sherman M
    Evidence-based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2016 Jan 12. pii: S0016-5085(16)00007.
    PubMed     Text format     Abstract available


  161. HIRSOVA P, Ibrahim SH, Krishnan A, Verma VK, et al
    Lipid-induced Signaling Causes Release of Inflammatory Extracellular Vesicles from Hepatocytes.
    Gastroenterology. 2016 Jan 4. pii: S0016-5085(15)01865.
    PubMed     Text format     Abstract available


  162. XUE R, Li R, Guo H, Guo L, et al
    Variable Extent of Intra-tumor Heterogeneity Revealed by Genomic Sequencing of Multiple Lesions in Patients with Hepatocellular Carcinoma.
    Gastroenterology. 2016 Jan 2. pii: S0016-5085(15)01861.
    PubMed     Text format     Abstract available


  163. KOI M, Garcia M, Choi C, Kim HR, et al
    Microsatellite Alterations with Allelic Loss at 9p24.2 Signify Less-aggressive Colorectal Cancer Metastasis.
    Gastroenterology. 2016 Jan 2. pii: S0016-5085(15)01860.
    PubMed     Text format     Abstract available


  164. LASSAILLY G, Caiazzo R, Mathurin P, Pattou F, et al
    Reply.
    Gastroenterology. 2016;150:284-5.
    PubMed     Text format    


  165. LIANGPUNSAKUL S, Crabb DW
    Early Detection of Alcoholic Liver Disease: Are We a Step Closer?
    Gastroenterology. 2016;150:29-31.
    PubMed     Text format    


  166. BYRNE CD, Targher G
    Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2016;150:7-10.
    PubMed     Text format    


  167. SANYAL AJ, Neuschwander-Tetri BA, Tonascia J
    End Points Must Be Clinically Meaningful for Drug Development in Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2016;150:11-3.
    PubMed     Text format    


  168. FABBRINI E, Tiemann Luecking C, Love-Gregory L, Okunade AL, et al
    Physiological Mechanisms of Weight Gain-Induced Steatosis in People With Obesity.
    Gastroenterology. 2016;150:79-81.
    PubMed     Text format     Abstract available


    December 2015
  169. MEHTA N, Heimbach J, Hirose R, Roberts JP, et al
    Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy?
    Gastroenterology. 2015 Dec 21. pii: S0016-5085(15)01748.
    PubMed     Text format    


  170. LENCIONI R, Braet F
    Novel Transarterial Biomimetic-based Nanoparticles for the Treatment of Hepatocellular Carcinoma.
    Gastroenterology. 2015 Dec 19. pii: S0016-5085(15)01817.
    PubMed     Text format    


  171. CUBERO FJ, Eugenio Zoubek M, Peng J, Hu W, et al
    Combined activities of JNK1 and JNK2 in hepatocytes protect against toxic liver injury.
    Gastroenterology. 2015 Dec 18. pii: S0016-5085(15)01814.
    PubMed     Text format     Abstract available


  172. VILAR-GOMEZ E, Friedman SL, Romero-Gomez M
    Reply: To PMID 25865049.
    Gastroenterology. 2015;149:1988-9.
    PubMed     Text format    


    November 2015
  173. MU X, Pradere JP, Affo S, Dapito DH, et al
    Epithelial Transforming Growth Factor-beta Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
    Gastroenterology. 2015 Nov 25. pii: S0016-5085(15)01721.
    PubMed     Text format     Abstract available


  174. GERHARD GS, Still CD, DiStefano JK
    High False-negative Rate for Nonalcoholic Steatohepatitis in Extreme Obesity.
    Gastroenterology. 2015 Nov 23. pii: S0016-5085(15)01582.
    PubMed     Text format    


  175. TAPPER EB, Leffler DA
    The Morbidity and Mortality Conference in Gastroenterology and Hepatology: An Important Cornerstone of Patient Safety and Optimal Care.
    Gastroenterology. 2015 Nov 22. pii: S0016-5085(15)01674.
    PubMed     Text format    


  176. HASSAN MM, Abdel-Wahab R, Li D, Kaseb AO, et al
    Reply: To PMID 25836985.
    Gastroenterology. 2015;149:1643-4.
    PubMed     Text format    


  177. LEE JH, Yoon JH
    Reply: To PMID 25747273.
    Gastroenterology. 2015;149:1640-1.
    PubMed     Text format    


    October 2015
  178. TEH JL, Lee KC, Tan KK
    An Unusual Cause of a Large Liver Abscess.
    Gastroenterology. 2015;149:e7-9.
    PubMed     Text format    


  179. MICHALOPOULOS GK, Khan Z
    Liver Stem Cells: Experimental Findings and Implications for Human Liver Disease.
    Gastroenterology. 2015;149:876-82.
    PubMed     Text format     Abstract available


    August 2015
  180. PEERY AF, Crockett SD, Barritt AS, Dellon ES, et al
    Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States.
    Gastroenterology. 2015 Aug 28. pii: S0016-5085(15)01242.
    PubMed     Text format     Abstract available


  181. WANG D, Fu L, Sun H, Guo L, et al
    Prostaglandin E Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Gastroenterology. 2015 Aug 7. pii: S0016-5085(15)01097.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: